Heart Disease
Google News
Updated: 17 hours 22 min ago
Why India must integrate dentistry at the core of its healthcare initiatives - ETHealthworld.com
Categories: Physical Diseases News
8 Common Medications Linked to Dehydration - Everyday Health
8 Common Medications Linked to Dehydration Everyday Health
Categories: Physical Diseases News
What Is Vibrational Energy? Definition, Benefits & More - Healthline
Categories: Physical Diseases News
6 science-backed benefits of omega-3 fatty acids and how to add more to your diet - Insider - INSIDER
Categories: Physical Diseases News
How are heart researchers using the Nobel Prize-winning genetic scissors? - British Heart Foundation
How are heart researchers using the Nobel Prize-winning genetic scissors? British Heart Foundation
Categories: Physical Diseases News
New Novartis Analyses for Investigational Inclisiran Demonstrate Consistently Effective and Sustained LDL-C Reduction - Cath Lab Digest
New Novartis Analyses for Investigational Inclisiran Demonstrate Consistently Effective and Sustained LDL-C Reduction Cath Lab Digest
Categories: Physical Diseases News
Data from contemporary registry confirms that four out of five patients with heart failure with reduced ejection fraction eligible for treatment with FARXIGA - Business Wire
Categories: Physical Diseases News
Data from contemporary registry confirms that four out of five patients with heart failure with reduced ejection fraction eligible for treatment with FARXIGA - Business Wire
Categories: Physical Diseases News
Data from contemporary registry confirms that four out of five patients with heart failure with reduced ejection fraction eligible for treatment with FARXIGA - Business Wire
Categories: Physical Diseases News
Data from contemporary registry confirms that four out of five patients with heart failure with reduced ejection fraction eligible for treatment with FARXIGA - Business Wire
Categories: Physical Diseases News
Data from contemporary registry confirms that four out of five patients with heart failure with reduced ejection fraction eligible for treatment with FARXIGA - Business Wire
Categories: Physical Diseases News
Data from contemporary registry confirms that four out of five patients with heart failure with reduced ejection fraction eligible for treatment with FARXIGA - Business Wire
Categories: Physical Diseases News
Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension - BioSpace
Categories: Physical Diseases News
Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension - BioSpace
Categories: Physical Diseases News
Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension - BioSpace
Categories: Physical Diseases News
Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension - BioSpace
Categories: Physical Diseases News
Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension - BioSpace
Categories: Physical Diseases News
Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension - BioSpace
Categories: Physical Diseases News
Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension - Business Wire
Categories: Physical Diseases News
